Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis.

Saved in:
Bibliographic Details
Title: Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis.
Authors: Hashimoto, Teppei1 (AUTHOR) te-hashimoto@hyo-med.ac.jp, Yoshida, Kohsuke2 (AUTHOR), Yokoyama, Yuichi3 (AUTHOR), Hashimoto, Naonori4 (AUTHOR), Kaneshiro, Kenta4 (AUTHOR), Yoshikawa, Takahiro1 (AUTHOR), Tateishi, Koji5 (AUTHOR), Terashima, Yasuhiro5 (AUTHOR), Matsui, Kiyoshi1 (AUTHOR), Hashiramoto, Akira4 (AUTHOR)
Source: Clinical & Experimental Immunology. Aug2023, Vol. 213 Issue 2, p209-220. 12p. 1 Diagram, 2 Charts, 5 Graphs.
Database: Academic Search Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 171961786
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Hashimoto%2C+Teppei%22">Hashimoto, Teppei</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> te-hashimoto@hyo-med.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Yoshida%2C+Kohsuke%22">Yoshida, Kohsuke</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yokoyama%2C+Yuichi%22">Yokoyama, Yuichi</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hashimoto%2C+Naonori%22">Hashimoto, Naonori</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kaneshiro%2C+Kenta%22">Kaneshiro, Kenta</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yoshikawa%2C+Takahiro%22">Yoshikawa, Takahiro</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tateishi%2C+Koji%22">Tateishi, Koji</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Terashima%2C+Yasuhiro%22">Terashima, Yasuhiro</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Matsui%2C+Kiyoshi%22">Matsui, Kiyoshi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hashiramoto%2C+Akira%22">Hashiramoto, Akira</searchLink><relatesTo>4</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Clinical+%26+Experimental+Immunology%22">Clinical & Experimental Immunology</searchLink>. Aug2023, Vol. 213 Issue 2, p209-220. 12p. 1 Diagram, 2 Charts, 5 Graphs.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=171961786
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cei/uxad064
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 209
    Titles:
      – TitleFull: Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hashimoto, Teppei
      – PersonEntity:
          Name:
            NameFull: Yoshida, Kohsuke
      – PersonEntity:
          Name:
            NameFull: Yokoyama, Yuichi
      – PersonEntity:
          Name:
            NameFull: Hashimoto, Naonori
      – PersonEntity:
          Name:
            NameFull: Kaneshiro, Kenta
      – PersonEntity:
          Name:
            NameFull: Yoshikawa, Takahiro
      – PersonEntity:
          Name:
            NameFull: Tateishi, Koji
      – PersonEntity:
          Name:
            NameFull: Terashima, Yasuhiro
      – PersonEntity:
          Name:
            NameFull: Matsui, Kiyoshi
      – PersonEntity:
          Name:
            NameFull: Hashiramoto, Akira
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: Aug2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 00099104
          Numbering:
            – Type: volume
              Value: 213
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Clinical & Experimental Immunology
              Type: main
ResultId 1